(Q35906816)

11 August 2017

1 reference

title

Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life (English)

1 reference

11 August 2017

0 references

1 reference

Martin Lambert

1

1 reference

PubMed ID

15461312

11 August 2017

Dieter Naber

series ordinal

2

1 reference

11 August 2017

1 January 2004

1 reference

11 August 2017

1 reference

11 August 2017

18 Suppl 2

1 reference

11 August 2017

5-17; discussion 41-3

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200418002-00002

11 August 2017

0 references

cites work

Symptoms, standards of living and subjective quality of life: a comparative study of schizophrenic and depressed out-patients.

1 reference

12 December 2020

Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life.

1 reference

12 December 2020

Behavioral toxicity of antipsychotic drugs.

1 reference

12 December 2020

Cognitive dysfunction at baseline predicts symptomatic 1-year outcome in first-episode schizophrenics

1 reference

12 December 2020

A mediational model of quality of life for individuals with severe mental health problems.

1 reference

12 December 2020

The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the Quality of Life Scale.

1 reference

12 December 2020

Psychometric properties of the Subjective Well-Being Under Neuroleptics scale and the Subjective Deficit Syndrome Scale.

1 reference

12 December 2020

Subjective quality of life: its relationship with clinician-rated and patient-rated psychopathology. The South-Verona Outcome Project 6.

1 reference

12 December 2020

Longitudinal analysis of subjective quality of life in schizophrenia: anxiety as the best symptom predictor.

1 reference

12 December 2020

Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline.

1 reference

12 December 2020

Evaluating quality-of-life measures for clinical trials in Germany

1 reference

12 December 2020

The impact of weight gain on quality of life among persons with schizophrenia.

1 reference

12 December 2020

Insight and Interpersonal Function in Schizophrenia

1 reference

12 December 2020

Neuroleptic dysphoria may be the missing link between schizophrenia and substance abuse

1 reference

12 December 2020

Motor and mental aspects of extrapyramidal syndromes

1 reference

12 December 2020

Convergent validation of quality of life assessments for persons with severe mental illnesses.

1 reference

12 December 2020

'Akinetic Depression' in Schizophrenia

1 reference

12 December 2020

Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life.

1 reference

12 December 2020

Patients' subjective experiences on antipsychotic medications: implications for outcome and quality of life

1 reference

12 December 2020

Cognitive effects of antipsychotics in schizophrenia and relationship to quality of life.

1 reference

12 December 2020

Measuring the quality of life of severely mentally ill people using the Lancashire Quality of Life Profile

1 reference

12 December 2020

Quality of life, loneliness, and social contact among long-term psychiatric patients.

1 reference

12 December 2020

Determinants of subjective quality of life in post acute patients with schizophrenia

1 reference

12 December 2020

Subjective and external assessments of quality of life in schizophrenia: relationship to insight.

1 reference

12 December 2020

The measurement of subjective experience in schizophrenia: the Subjective Deficit Syndrome Scale.

1 reference

12 December 2020

[Subjective experience and quality of life in schizophrenia]

1 reference

12 December 2020

The relationship of personality dimensions as measured by the temperament and character inventory and quality of life in individuals with schizophrenia or schizoaffective disorder living in the community.

1 reference

12 December 2020

Neuroleptics and the neuroleptic-induced deficit syndrome.

1 reference

12 December 2020

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

12 December 2020

Assessing psychological distress in psychiatric patients: validation of the Talbieh Brief Distress Inventory

1 reference

12 December 2020

Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence

1 reference

12 December 2020

The impact of side-effects of antipsychotic agents on life satisfaction of schizophrenia patients: a naturalistic study.

1 reference

12 December 2020

Dysphoric subjective response to neuroleptics in schizophrenia: relationship to extrapyramidal side effects and symptomatology

1 reference

12 December 2020

The course of depressive symptoms in predicting relapse in schizophrenia: a double-blind, randomized comparison of olanzapine and risperidone

1 reference

12 December 2020

The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia

1 reference

12 December 2020

Evaluation of the quality of life of the schizophrenic outpatient: a checklist

1 reference

12 December 2020

Subjective response to antipsychotics in schizophrenic patients: clinical implications and related factors.

1 reference

12 December 2020

Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs

1 reference

12 December 2020

A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables.

1 reference

12 December 2020

Personal evaluation of transitions in treatment (PETiT):a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia

1 reference

12 December 2020

Predicting quality of life from symptomatology in schizophrenia at exacerbation and stabilization.

1 reference

12 December 2020

Neuroleptic dysphoria

1 reference

12 December 2020

Quality of life outcomes in mental illness: schizophrenia, mood and anxiety disorders

1 reference

12 December 2020

[Quality of life. Construct validation and the development of a modular system]

1 reference

12 December 2020

Quality of life and coping with schizophrenia symptoms.

1 reference

12 December 2020

Quantitative and qualitative aspects of the social network in schizophrenic patients living in the community. Relationship to sociodemographic characteristics and clinical factors and subjective quality of life.

1 reference

12 December 2020

A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity

1 reference

12 December 2020

Attitudes of patients toward the first psychotic episode and the start of treatment.

1 reference

12 December 2020

Attitudes toward antipsychotics among outpatient clinic attendees with schizophrenia

1 reference

12 December 2020

Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients.

1 reference

12 December 2020

The Wisconsin Quality of Life Index: a multidimensional model for measuring quality of life.

1 reference

12 December 2020

Determinants of quality of life at first presentation with schizophrenia.

1 reference

12 December 2020

Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic study

1 reference

12 December 2020

Subjective and objective evaluation of treating schizophrenia with classic or atypical drugs

1 reference

12 December 2020

Response to antipsychotic medication: the doctor's and the consumer's view

1 reference

12 December 2020

Subjective response to neuroleptics in schizophrenia

1 reference

12 December 2020

Quality of life in schizophrenia: insight and subjective response to neuroleptics.

1 reference

12 December 2020

Predictors of subjective quality of life in schizophrenic patients living in the community. A Nordic multicentre study

1 reference

12 December 2020

The effects of psychiatric symptoms on quality of life assessments among the chronic mentally ill.

1 reference

12 December 2020

Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance

1 reference

12 December 2020

Neuropsychological functioning as a moderator of the relationship between psychosocial functioning and the subjective experience of self and life in schizophrenia

1 reference

12 December 2020

Quality of life--as defined by schizophrenic patients and psychiatrists.

1 reference

12 December 2020

Assessing depression in schizophrenia: the Calgary Depression Scale

1 reference

12 December 2020

Objective and subjective extrapyramidal side effects in schizophrenia: their relationships with negative and depressive symptoms

1 reference

12 December 2020

Comparison of quality of life with standard of living in schizophrenic out-patients

1 reference

12 December 2020

Predictors of quality of life in major psychoses: a naturalistic follow-up study.

1 reference

12 December 2020

Predicting changes in domain-specific quality of life of schizophrenia patients.

1 reference

12 December 2020

The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome

1 reference

12 December 2020

Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia.

1 reference

12 December 2020

Subjective Well-being and Initial Dysphoric Reaction under Antipsychotic Drugs - Concepts, Measurement and Clinical Relevance

1 reference

12 December 2020

Subjective side effects of neuroleptic agents

1 reference

12 December 2020

Subjective well-being and quality of life under atypical antipsychotic treatment

1 reference

12 December 2020

Personality and self-variables: important determinants of subjective quality of life in schizophrenia out-patients.

1 reference

12 December 2020

Neurocognitive deficits and quality of life in outpatients with schizophrenia

1 reference

12 December 2020

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

1 reference

12 December 2020

Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability.

1 reference

12 December 2020

Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial

1 reference

12 December 2020

A comparison of patients' and prescribers' beliefs about neuroleptic side-effects: prevalence, distress and causation

1 reference

12 December 2020

Quality of life of schizophrenic patients on medications and implications for new drug trials

1 reference

12 December 2020

10.2165/00023210-200418002-00002

Identifiers

DOI

0 references

Dimensions Publication ID

0 references

1 reference

PubMed ID

15461312